In a recent cross-sectional study led by Dr. Antonia Topalova-Dimitrova, a significant link was found between vitamin D deficiency and inflammation in patients with Inflammatory Bowel Disease (IBD). The study revealed a 32.6% prevalence of vitamin D deficiency and a 66.3% prevalence of insufficiency in IBD patients compared to healthy controls. Lower vitamin D levels were correlated with higher inflammatory markers. Could addressing vitamin D deficiency in IBD patients complement existing treatments, potentially reducing disease severity and relapse risks? Further research is needed to establish causation, but Dr. Topalova-Dimitrova emphasizes the importance of evaluating vitamin D levels in IBD patients to mitigate associated risks.
Source: https://journals.lww.com/md-journal/pages/default.aspx
